Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 85


Atypical Human Effector/Memory CD4+ T Cells With a Naive-Like Phenotype.

Caccamo N, Joosten SA, Ottenhoff THM, Dieli F.

Front Immunol. 2018 Dec 3;9:2832. doi: 10.3389/fimmu.2018.02832. eCollection 2018. Review.


Downregulation of miRNA17-92 cluster marks Vγ9Vδ2 T cells from patients with rheumatoid arthritis.

Guggino G, Orlando V, Saieva L, Ruscitti P, Cipriani P, La Manna MP, Giacomelli R, Alessandro R, Triolo G, Ciccia F, Dieli F, Caccamo N.

Arthritis Res Ther. 2018 Oct 22;20(1):236. doi: 10.1186/s13075-018-1740-7.


Buffy coat-derived platelets cryopreserved using a new method: Results from in vitro studies.

Napolitano M, Mancuso S, Lo Coco L, Arfò PS, Raso S, De Francisci G, Dieli F, Caccamo N, Reina A, Dolce A, Agliastro R, Siragusa S.

Transfus Apher Sci. 2018 Aug;57(4):578-581. doi: 10.1016/j.transci.2018.07.020. Epub 2018 Aug 1.


γδ T Cells and Tumor Microenvironment: From Immunosurveillance to Tumor Evasion.

Lo Presti E, Pizzolato G, Corsale AM, Caccamo N, Sireci G, Dieli F, Meraviglia S.

Front Immunol. 2018 Jun 15;9:1395. doi: 10.3389/fimmu.2018.01395. eCollection 2018. Review.


Human CD4 T-Cells With a Naive Phenotype Produce Multiple Cytokines During Mycobacterium Tuberculosis Infection and Correlate With Active Disease.

Orlando V, La Manna MP, Goletti D, Palmieri F, Lo Presti E, Joosten SA, La Mendola C, Buccheri S, Ottenhoff THM, Dieli F, Caccamo N.

Front Immunol. 2018 May 23;9:1119. doi: 10.3389/fimmu.2018.01119. eCollection 2018.


Impact of antiretroviral and tuberculosis therapies on CD4+ and CD8+ HIV/M. tuberculosis-specific T-cell in co-infected subjects.

Chiacchio T, Petruccioli E, Vanini V, Cuzzi G, La Manna MP, Orlando V, Pinnetti C, Sampaolesi A, Antinori A, Caccamo N, Goletti D.

Immunol Lett. 2018 Jun;198:33-43. doi: 10.1016/j.imlet.2018.04.001. Epub 2018 Apr 7.


Identification of plasma biomarkers for discrimination between tuberculosis infection/disease and pulmonary non tuberculosis disease.

La Manna MP, Orlando V, Li Donni P, Sireci G, Di Carlo P, Cascio A, Dieli F, Caccamo N.

PLoS One. 2018 Mar 15;13(3):e0192664. doi: 10.1371/journal.pone.0192664. eCollection 2018.


Detailed characterization of human Mycobacterium tuberculosis specific HLA-E restricted CD8+ T cells.

Prezzemolo T, van Meijgaarden KE, Franken KLMC, Caccamo N, Dieli F, Ottenhoff THM, Joosten SA.

Eur J Immunol. 2018 Feb;48(2):293-305. doi: 10.1002/eji.201747184. Epub 2017 Dec 15.


TBVAC2020: Advancing Tuberculosis Vaccines from Discovery to Clinical Development.

Kaufmann SHE, Dockrell HM, Drager N, Ho MM, McShane H, Neyrolles O, Ottenhoff THM, Patel B, Roordink D, Spertini F, Stenger S, Thole J, Verreck FAW, Williams A; TBVAC2020 Consortium.

Front Immunol. 2017 Oct 4;8:1203. doi: 10.3389/fimmu.2017.01203. eCollection 2017. Review.


Quantitative and qualitative profiles of circulating monocytes may help identifying tuberculosis infection and disease stages.

La Manna MP, Orlando V, Dieli F, Di Carlo P, Cascio A, Cuzzi G, Palmieri F, Goletti D, Caccamo N.

PLoS One. 2017 Feb 16;12(2):e0171358. doi: 10.1371/journal.pone.0171358. eCollection 2017.


Activation and selective IL-17 response of human Vγ9Vδ2 T lymphocytes by TLR-activated plasmacytoid dendritic cells.

Lo Presti E, Caccamo N, Orlando V, Dieli F, Meraviglia S.

Oncotarget. 2016 Sep 20;7(38):60896-60905. doi: 10.18632/oncotarget.11755.


Inflammation and the coagulation system in tuberculosis: Tissue Factor leads the dance.

Caccamo N, Dieli F.

Eur J Immunol. 2016 Feb;46(2):303-6. doi: 10.1002/eji.201546225.


Intracellular Cytokine Staining and Flow Cytometry: Considerations for Application in Clinical Trials of Novel Tuberculosis Vaccines.

Smith SG, Smits K, Joosten SA, van Meijgaarden KE, Satti I, Fletcher HA, Caccamo N, Dieli F, Mascart F, McShane H, Dockrell HM, Ottenhoff TH; TBVI TB Biomarker Working Group.

PLoS One. 2015 Sep 14;10(9):e0138042. doi: 10.1371/journal.pone.0138042. eCollection 2015.


Granzyme A as a potential biomarker of Mycobacterium tuberculosis infection and disease.

Guggino G, Orlando V, Cutrera S, La Manna MP, Di Liberto D, Vanini V, Petruccioli E, Dieli F, Goletti D, Caccamo N.

Immunol Lett. 2015 Aug;166(2):87-91. doi: 10.1016/j.imlet.2015.05.019. Epub 2015 Jun 5.


Human CD8+ T-cells recognizing peptides from Mycobacterium tuberculosis (Mtb) presented by HLA-E have an unorthodox Th2-like, multifunctional, Mtb inhibitory phenotype and represent a novel human T-cell subset.

van Meijgaarden KE, Haks MC, Caccamo N, Dieli F, Ottenhoff TH, Joosten SA.

PLoS Pathog. 2015 Mar 24;11(3):e1004671. doi: 10.1371/journal.ppat.1004671. eCollection 2015 Mar.


Human CD8 T lymphocytes recognize Mycobacterium tuberculosis antigens presented by HLA-E during active tuberculosis and express type 2 cytokines.

Caccamo N, Pietra G, Sullivan LC, Brooks AG, Prezzemolo T, La Manna MP, Di Liberto D, Joosten SA, van Meijgaarden KE, Di Carlo P, Titone L, Moretta L, Mingari MC, Ottenhoff TH, Dieli F.

Eur J Immunol. 2015 Apr;45(4):1069-81. doi: 10.1002/eji.201445193. Epub 2015 Feb 17. Erratum in: Eur J Immunol. 2019 Jun;49(6):971.


Functional Signatures of Human CD4 and CD8 T Cell Responses to Mycobacterium tuberculosis.

Prezzemolo T, Guggino G, La Manna MP, Di Liberto D, Dieli F, Caccamo N.

Front Immunol. 2014 Apr 22;5:180. doi: 10.3389/fimmu.2014.00180. eCollection 2014. Review.


Efficacy and safety of γδT cell-based tumor immunotherapy: a meta-analysis.

Buccheri S, Guggino G, Caccamo N, Li Donni P, Dieli F.

J Biol Regul Homeost Agents. 2014 Jan-Mar;28(1):81-90.


Butyrophilin 3A1 presents phosphoantigens to human γδ T cells: the fourth model of antigen presentation in the immune system.

Dieli F, Fadda R, Caccamo N.

Cell Mol Immunol. 2014 Mar;11(2):123-5. doi: 10.1038/cmi.2013.54. Epub 2013 Nov 25. No abstract available.


Combining conventional chemotherapy and γδ T cell-based immunotherapy to target cancer-initiating cells.

Todaro M, Meraviglia S, Caccamo N, Stassi G, Dieli F.

Oncoimmunology. 2013 Sep 1;2(9):e25821. Epub 2013 Jul 29.

Supplemental Content

Loading ...
Support Center